ADA Pharma is rated 3 out of 5 in the category biotechnology. Read and write reviews about ADA Pharma. Development of biotechnology of production of ecologically compatible standardised raw materials of medicinal plants as exemplified by Rhodiola rosea. Plants have a long selection cycle and an uncontrollable contents of biologically active substances (BAS). What complicates industrial production of medicines. Rhodiola rosea is a valuable medicinal plant. It is antioxidant, antidepressant and anticarcinogenic. It stimulates the central nervous system. We have produced micro clones of Rhodiola rosea with a high content of BAS. Later, these samples can be maintained in culture, grown up in a hydroponic hothouse or in fields, converted into a cell culture and grown up in a bioreactor. Conversion of Rhodiola rosea into culture has great prospects both for industrial production of standardised medicinal raw materials, and for preservation of this rare plant in nature.
Company size
1-10 employees
Headquarters
Tallinn, Harjumaa